Perrigo (PRGO) Operating Income (2012 - 2026)
Perrigo (PRGO) posted quarterly Operating Income of -$372.3 million for Q1 2026, down 893.82% year-over-year from $46.9 million in Q1 2025, and up 71.07% quarter-over-quarter from -$1.3 billion in Q4 2025.
Perrigo (PRGO) Operating Income (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Operating Income for 15 consecutive years, with -$372.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Income fell 893.82% year-over-year to -$372.3 million; the TTM figure through Mar 2026 stood at -$1.5 billion (down 816.93% YoY), while the FY2025 annual figure was -$1.1 billion, down 1093.98% from the prior year.
- Operating Income rose to -$372.3 million in Q1 2026 per PRGO's latest filing, from -$1.3 billion in the prior quarter.
- Across five years, Operating Income topped out at $114.2 million in Q4 2024 and bottomed at -$1.3 billion in Q4 2025.
- Historically, Operating Income has averaged -$67.7 million across 5 years, with a median of $33.1 million in 2022.
- Annual changes were most pronounced in 2023 — Operating Income jumped 923.19% — and 2025, when it tumbled 1227.06%.
- Perrigo's Operating Income stood at $31.0 million in 2022, then slumped by 150.32% to -$15.6 million in 2023, then jumped by 832.05% to $114.2 million in 2024, then sank by 1227.06% to -$1.3 billion in 2025, then soared by 71.07% to -$372.3 million in 2026.
- Business Quant data shows PRGO's Operating Income at -$372.3 million in Q1 2026, -$1.3 billion in Q4 2025, and $72.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Perrigo | 1.88 Bn | 1.48 Bn | 313.90 Mn | 23.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 23.50 Mn |
| Mar 28, 2026 | -372.30 Mn |
| Dec 31, 2025 | -1.29 Bn |
| Sep 27, 2025 | 72.60 Mn |
| Jun 28, 2025 | 45.40 Mn |
| Mar 29, 2025 | 46.90 Mn |
| Dec 31, 2024 | 114.20 Mn |
| Sep 28, 2024 | 80.40 Mn |
| Jun 29, 2024 | -26.50 Mn |
| Mar 30, 2024 | -55.20 Mn |
| Dec 31, 2023 | -15.60 Mn |
| Sep 30, 2023 | 62.10 Mn |
| Jul 1, 2023 | 56.80 Mn |
| Apr 1, 2023 | 48.50 Mn |
| Dec 31, 2022 | 31.00 Mn |
| Oct 1, 2022 | 33.10 Mn |
| Jul 2, 2022 | -6.90 Mn |
| Apr 2, 2022 | 21.70 Mn |
| Dec 31, 2021 | 46.70 Mn |
| Oct 2, 2021 | 438.30 Mn |